Fibrotouch联合FIB-4指数对肝硬化患者发生并发症的预测价值

doi:10.3969/j.issn.1672-5069.2017.02.012

摘要/Abstract

摘要： 目的评价Fibrotouch联合FIB-4指数对肝硬化患者发生并发症的预测价值。方法 2015年6月～2016年2月我院诊治的肝硬化患者，使用Fibrotouch测量其肝脏硬度值（LSM），计算其FIB-4指数。比较不同Child-Pugh分级患者、代偿期与失代偿期肝硬化患者、单一并发症与多种并发症肝硬化患者LSM和FIB-4指数差异。采用Logistic回归分析进行风险预测，应用受试者工作特征曲线（ROC）评价诊断试验的效能。结果 Child-Pugh A级患者LSM为（17.09±7.15）kPa，显著低于Child-Pugh B级【（27.37±5.83）kPa，P＜0.01】或Child-Pugh C级【（34.26±9.10）kPa，P＜0.01】患者；Child-Pugh A级患者FIB-4指数为（3.69±2.66），显著低于Child-Pugh B级【（6.67±4.30），P＜0.01】或Child-Pugh C级【（8.49±4.69），P＜0.01】；代偿期肝硬化患者LSM为（17.14±7.27）Kpa，显著低于失代偿期肝硬化患者【（29.11±7.79）kPa，P＜0.01】；代偿期肝硬化患者FIB-4指数为（3.66±2.70），显著低于失代偿期肝硬化患者【（7.14±4.44），P＜0.01】；单一并发症组LSM为（26.98±6.03）kPa，显著低于多种并发症组【(34.95±9.12）kPa，P＜0.01】；单一并发症组FIB-4指数为（6.56±4.22），显著低于多种并发症组【（8.74±4.72），P＜0.01】；Fibrotouch和FIB-4指数联合预测肝硬化并发症的AUC为0.903，显著高于FIB-4指数单独预测时的AUC（0.765，P＜0.01）。结论 Fibrotouch与FIB-4指数联合对肝硬化患者发生并发症的预测价值较高，值得进一步研究。

关键词: 肝硬化, 并发症, 瞬时弹性成像技术, FIB-4指数, 诊断

Abstract: Objective To evaluate the predictive value of complications by Fibrotouch combined with FIB-4 index in patients with liver cirrhosis.Methods Between June 2015 and February 2016， the patients with liver cirrhosis in our hospital were recruited in this study. Fibrotouch was applied to detect the liver stiffness measurement（LSM），and FIB-4 index was calculated. The differences in LSM and FIB-4 index among patients with different Child-Pugh class，patients with compensated or decompensated cirrhosis and patients with single complications or multiple complications were analyzed. Logistic analysis was used to predict the risk for occurrence of complications，and receiver operating characteristic curves were used to evaluate its predictive value.Results The LSM in patients with Child-Pugh class A was （17.09±7.15） kPa，significantly lower than that in with Child-Pugh class B [（27.37±5.83）kPa，P＜0.01] or that in with Child-Pugh class C[（34.26±9.10） kPa，P＜0.01]；the FIB-4 index in patients with Child-Pugh class A was（3.69±2.66），significantly lower than that in with Child-Pugh class B[（6.67±4.30），P＜0.01] or that in with Child-Pugh class C[（8.49±4.69），P＜0.01]；The LSM in compensated cirrhosis patients was（17.14±7.27）kPa，significantly lower than that in the decompensated cirrhosis patients [（29.11±7.79）kPa，P＜0.01]；the FIB-4 index in compensated cirrhosis patients was （3.66±2.70），significantly lower than that in the decompensated cirrhosis patients[（7.14±4.44），P＜0.01]；The LSM in patients with single complication was（26.98±6.03）kPa，significantly lower than that in with multiple complications [（34.95±9.12）kPa，P＜0.01]；the FIB-4 index in single complication patients was （6.56±4.22），significantly lower than that in multiple complications patients[（8.74±4.72），P＜0.01]；The AUC of Fibrotouch combined with FIB-4 index to predict complications in patients with liver cirrhosis was 0.903，significantly higher than that by FIB-4 index alone（0.765，P＜0.01）.Conclusion Fibrotouch combined with FIB-4 index can improve the predictive value of complications in patients with liver cirrhosis，which is worthy of clinical application.

Key words: Liver cirrhosis, Complications, Transient elastic imaging technology, FIB-4 index, Diagnosis

刘艳，赵卫峰，甘建和，浦永兰，王杰，范斌，李仲华. Fibrotouch联合FIB-4指数对肝硬化患者发生并发症的预测价值[J]. 实用肝脏病杂志, 2017, 20(2): 175-178.

Liu Yan，Zhao Weifeng，Gan Jianhe， et al. Predictive value of Fibrotouch combined with FIB-4 index in prediction of complications in patients with liver cirrhosis[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(2): 175-178.

参考文献

[1] Rockey DC，Caldwell SH，Goodman ZD，et al．Liver biopsy.Hepatology，2009，49（3）:1017-1044．
[2] Myers RP，Fong A，Shaheen AA．Utilization rates，complications and costs of percutaneous liver biopsy:a population-based study including 4275 biopsies．Liver Int，2008，28（5）:705-712．
[3] Bedossa P，Dargère D，Paradis V．Sampling variability of liver fibrosis in chronic hepatitis C．Hepatology，2003，38（6）:1449-1457．
[4] Myers RP，Pomier-Layrargues G，Kirsch R，et al．Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients．Hepatology，2012，55（1）:199-208．
[5] 王荣琦，任伟光，赵素贤,等. 瞬时弹性成像技术与多参数模型评估慢性肝病肝纤维化程度的临床研究. 中华肝脏病杂志，2015，23（4）:265-269．
[6] 王春妍，程晓静，孟超,等．Fibrotest对慢性乙型肝炎肝纤维化程度诊断效能的评估价值. 中华肝脏病杂志，2015，23（10）:738-741．
[7] Dincses E，Yilmaz Y．Diagnostic usefulness of FibroMeter VCTE for hepatic fibrosis in patients with nonalcoholic fatty liver disease．Eur J Gastroenterol Hepatol，2015，27（10）:1149-1153．
[8] Li Y，Chen Y，Zhao Y．The diagnostic value of the FIB-4 index for staging hepatitis B-related fibrosis:a Meta-analysis. PLoS One，2014，9（8）:e105728.
[9] 李欣，马红．血清学模型与Fibroscan联合诊断肝纤维化研究进展．实用肝脏病杂志，2012，15（5）:472-474．
[10] Nunes D，Fleming C，Offner G，et al．Noninvasive markers of liver fibrosis are highly predictive of liver-related death in a cohort of HCV-infected individuals with and without HIV infection．Am J Gastroenterol，2010，105（6）:1346-1353.
[11] Klibansky DA，Mehta SH，Curry M，et al．Transient elastography for predicting clinical outcomes in patients with chronic liver disease．J Viral Hepat，2012，19（2）:e184-93．
[12] 科技部十二五重大专项联合课题组.乙型肝炎病毒相关肝硬化的临床诊断、评估和抗病毒治疗的综合管理. 中华肝脏病杂志,2014，22（5）:327-335．
[13] Wong GL．Transient elastography: Kill two birds with one stone World J Hepatol，2013，5（5）:264－274．
[14] 刘芳，李庭红，韩涛,等．瞬时弹性成像在肝硬化门静脉高压中的临床评价．中华肝脏病杂志，2013，21（11）:840-844.
[15] 韩萍，纪冬，张健,等．瞬时弹性成像检测对肝硬化腹水的预测作用研究．解放军医学杂志，2011，36（11）:1143-1144．
[16] Vallet-Pichard A，Mallet V，Nalpas B，et al．Fib-4:an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. Hepatology，2007，46（1）:32-6．
[17] Zhang W，Wang L，Wang LH，et al. Liver stiffness measurement, better than APRI, Fibroindex，Fib-4，and NBI gastroscopy, predicts portal hypertension in patients with cirrhosis．Cell Biochem Biophys，2015，71（2）:865-873．
[18] Pang JX，Zimmer S，Niu S，et al．Liver stiffness by transient elastography predicts liver-related complications and mortality in patients with chronic liver disease．PLoS One，2014，22（4）:e95776.